FDA

Latest News

Suman-stock.adobe.com
FDA Grants Accelerated Approval to Vanrafia for IgAN, a Rare Kidney Disease

April 3rd 2025

Vanrafia reduces proteinuria in adults with primary immunoglobulin A nephropathy (IgAN). It has a wholesale acquisition cost of $162,500 annually.

FDA Approves Two More Denosumab Biosimilars, Conexxence and Bomyntra
FDA Approves Two More Denosumab Biosimilars, Conexxence and Bomyntra

March 27th 2025

Yurii Kibalnik-stock.adobe.com
FDA Approves First Drug for Excess Hunger in Prader-Willi Syndrome

March 27th 2025

FDA Approves UTI Antibiotic, Blujepa
FDA Approves UTI Antibiotic, Blujepa

March 26th 2025

FDA Approves Cabometyx to Treat Advanced Pancreatic Cancer
FDA Approves Cabometyx to Treat Advanced Pancreatic Cancer

March 26th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.